Horizon Therapeutics PLC's orphan drug TEPEZZA is helping +4,000 people with thyroid eye disease
Register to read the full analysis —or— Upgrade to access more features
#IMPACT
#IMPAAKT
#TEPEZZA
#rare eye diseases
#EYES
#HORIZON THERAP
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.